Lundbeck Is Said to Express Interest in Buying Xeris Biopharma
H Lundbeck A/S has expressed interest in acquiring Xeris Biopharma Holdings Inc., a commercial-stage drugmaker, people familiar with the matter said.
Related discussion groups
No group discusses this yet. Start a discussion group and attach this story.